Jill Gilbert
Publications by Year
Research Areas
Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Cancer Diagnosis and Treatment, Oral health in cancer treatment, Lung Cancer Research Studies
Most-Cited Works
- → Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study(2017)643 cited
- → NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018(2018)624 cited
- → Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma(2005)592 cited
- → E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group(2017)493 cited
- → Head and Neck Cancers(2011)415 cited
- → NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017(2017)376 cited
- → Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study(2015)332 cited
- → Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC(2018)306 cited
- → Head and Neck Cancers, Version 2.2014(2014)280 cited
- → Dysphagia in Head and Neck Cancer Patients Treated With Radiation: Assessment, Sequelae, and Rehabilitation(2008)271 cited